Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph T Madak

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Topics in Medicinal Chemistry|March 4, 2015
Membrane permeable lipophilic cations as mitochondrial directing groupsJoseph T Madak, Nouri Neamati
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 24, 2017
Design, Synthesis, and Characterization of Brequinar Conjugates as Probes to Study DHODH InhibitionJoseph T Madak, Christine R Cuthbertson, Wenmin Chen, et al.
Pharmacology & Therapeutics|October 23, 2018
Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancerJoseph T Madak, Armand Bankhead, Christine R Cuthbertson, et al.
ACS Pharmacology & Translational Science|December 21, 2020
The Dihydroorotate Dehydrogenase Inhibitor Brequinar Is Synergistic with ENT1/2 InhibitorsChristine R Cuthbertson, Hui Guo, Armita Kyani, et al.
Journal of Medicinal Chemistry|May 5, 2018
Design, Synthesis, and Biological Evaluation of 4-Quinoline Carboxylic Acids as Inhibitors of Dihydroorotate DehydrogenaseJoseph T Madak, Christine R Cuthbertson, Yoshinari Miyata, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Topics in Medicinal Chemistry|March 4, 2015
Membrane permeable lipophilic cations as mitochondrial directing groupsJoseph T Madak, Nouri Neamati
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 24, 2017
Design, Synthesis, and Characterization of Brequinar Conjugates as Probes to Study DHODH InhibitionJoseph T Madak, Christine R Cuthbertson, Wenmin Chen, et al.
Pharmacology & Therapeutics|October 23, 2018
Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancerJoseph T Madak, Armand Bankhead, Christine R Cuthbertson, et al.
ACS Pharmacology & Translational Science|December 21, 2020
The Dihydroorotate Dehydrogenase Inhibitor Brequinar Is Synergistic with ENT1/2 InhibitorsChristine R Cuthbertson, Hui Guo, Armita Kyani, et al.
Journal of Medicinal Chemistry|May 5, 2018
Design, Synthesis, and Biological Evaluation of 4-Quinoline Carboxylic Acids as Inhibitors of Dihydroorotate DehydrogenaseJoseph T Madak, Christine R Cuthbertson, Yoshinari Miyata, et al.
Pageof 1